Mark Brunner, MD
Gastroenterology · Danville, KYNPI 1053386060
Payments from drug & device makers
Across 337 payments — averaging $18.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
- Takeda Pharmaceuticals U.S.A., Inc.$563
- Johnson & Johnson$308
- Gilead$217
- Sanofi$210
- plus $2K from 30 others
What the payments were for
- Food & beverage$6,070100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 94 | $1,703 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 87 | $1,448 |
| Takeda Pharmaceuticals U.S.A., Inc. | 31 | $563 |
| Johnson & Johnson | 9 | $308 |
| Gilead | 11 | $217 |
| Sanofi | 12 | $210 |
| Regeneron Healthcare Solutions, Inc. | 10 | $204 |
| Intercept Pharmaceuticals, Inc. | 8 | $132 |
| Lilly USA, LLC | 5 | $121 |
| Ironwood Pharmaceuticals, Inc | 7 | $116 |
| Phathom Pharmaceuticals, Inc. | 8 | $115 |
| QOL Medical, LLC | 6 | $108 |
| Braintree Laboratories, Inc. | 6 | $95 |
| Merck | 5 | $77 |
| Madrigal Pharmaceuticals | 3 | $72 |
| Ardelyx, Inc. | 4 | $67 |
| Redhill Biopharma Inc. | 4 | $63 |
| Bristol Myers Squibb | 3 | $57 |
| Boston Scientific | 2 | $42 |
| Pfizer | 3 | $42 |
| Nestle Healthcare Nutrition Inc. | 2 | $42 |
| Fresenius Kabi USA, LLC | 2 | $32 |
| Ipsen Biopharmaceuticals, Inc | 2 | $31 |
| ERBE USA Inc | 1 | $20 |
| Evoke Pharma, Inc. | 1 | $20 |
| Daiichi Sankyo Inc. | 1 | $18 |
| Alnylam Pharmaceuticals Inc. | 1 | $18 |
| Shionogi Inc | 1 | $17 |
| Alfasigma USA, Inc. | 1 | $17 |
| Ambu Inc. | 1 | $15 |
| Pharmacosmos Therapeutics Inc. | 1 | $15 |
| Shire North American Group Inc | 1 | $14 |
| AMAG Pharmaceuticals, Inc. | 1 | $14 |
| Azurity Pharmaceuticals, Inc. | 1 | $14 |
| Organon | 1 | $13 |
| Romark Laboratories, LC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Tremfya$143
How this compares
$6,070 in reported general payments places this provider in the 60th percentile of 207 gastroenterology providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other gastroenterology in Danville
- Ryan CarbaughDanville$10K
- Gerald DrydenLouisville$3.5M
- Michael JonesCrestview Hills$1.9M
- Jens RosenauLexington$1.6M
- Matthew CaveLouisville$916K
- Deborah FlomenhoftLexington$905K
- Michael KreaseLouisville$694K
- Zahid SaeedCrestview Hills$442K
- Thomas AbellLouisville$375K
- Sunana SohiLouisville$220K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.